SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-16-625609
Filing Date
2016-06-20
Accepted
2016-06-20 06:31:34
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-1/A d121613ds1a.htm S-1/A 850484
2 EX-1.1 d121613dex11.htm EX-1.1 162529
3 EX-5.1 d121613dex51.htm EX-5.1 4743
4 EX-23.1 d121613dex231.htm EX-23.1 1368
5 GRAPHIC g1216131.jpg GRAPHIC 7469
6 GRAPHIC g121613g29c11.jpg GRAPHIC 49546
7 GRAPHIC g121613g29y89.jpg GRAPHIC 53399
8 GRAPHIC g121613g33h38.jpg GRAPHIC 110854
9 GRAPHIC g121613g42o32.jpg GRAPHIC 51754
10 GRAPHIC g121613g54a33.jpg GRAPHIC 104763
11 GRAPHIC g121613g54l52.jpg GRAPHIC 54893
12 GRAPHIC g121613g69g47.jpg GRAPHIC 41435
13 GRAPHIC g121613g75c47.jpg GRAPHIC 105444
14 GRAPHIC g121613g75x49.jpg GRAPHIC 112905
15 GRAPHIC g121613g87r11.jpg GRAPHIC 40174
  Complete submission text file 0001193125-16-625609.txt   2030156
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-211976 | Film No.: 161721288
SIC: 2834 Pharmaceutical Preparations